[CH3:1][C:2]([O:32]C1CCCCO1)([CH2:27][CH2:28][C:29]#[C:30][CH3:31])/[CH:3]=[CH:4]/[C@@H:5]1[C@@H:9]([CH2:10]/[CH:11]=[CH:12]\[CH2:13][CH2:14][CH2:15][C:16]([OH:18])=[O:17])[C:8](=[O:19])[CH2:7][C@H:6]1[O:20]C1CCCCO1>C(O)(=O)C.O.C1COCC1>[OH:20][C@H:6]1[C@H:5](/[CH:4]=[CH:3]/[C:2]([OH:32])([CH3:1])[CH2:27][CH2:28][C:29]#[C:30][CH3:31])[C@@H:9]([CH2:10]/[CH:11]=[CH:12]\[CH2:13][CH2:14][CH2:15][C:16]([OH:18])=[O:17])[C:8](=[O:19])[CH2:7]1500 mg. of (5Z,13E)-(11R,15RS)-15-methyl-9-oxo-11,15-bis(tetrahydropyran-2-yloxy)-5,13-prostadien-18-ynoic acid is agitated for 16 hours at 20° with 15 ml. of a mixture of glacial acetic acid/water/THF (65/35/10), then evaporated under vacuum, and the remainder purified by column chromatography on silica gel. With methylene chloride/5% methanol, 260 mg. of the title compound is obtained in the form of an oil.